Check Out Gregory Austin's LinkedIn Stats (Last 30 Days)

“Where did the drug actually go?” That one question can determine whether a clinical candidate advances or gets shut down. In a packed session, Matt Silva, PhD (CEO of Emit Imaging), introduced one of the most eye-opening technologies I’ve seen in a while: Cryo-Fluorescence Tomography (CFT) — a high-res, 3D imaging method that allows you to map gene or cell therapies across an entire animal with voxel-level clarity. Imagine: ✔️ Seeing where your AAV vector actually expresses (not just assuming based on IHC or PCR) ✔️ Spotting unexpected signals in the jaw, tongue, or marrow before they surprise regulators ✔️ Screening out poor candidates early, based on whole-body distribution patterns ✔️ Multiplexing different fluorophores to evaluate delivery, expression, and clearance in one run And all of this is ex vivo — integrating seamlessly with your existing workflow (tissue banking, histology, mass spec, etc.). This isn't just pretty imaging. It’s a decision-making engine. CFT helped kill a candidate with unexpected marrow uptake. It revealed sub-organ signals in lymph nodes, pancreas, and even dental roots. This is not something you'd casually catch on 2D images or bulk PCR. Big thanks to Matt and the Emit team for pushing the envelope. #drugdevelopment #bioimaging #genetherapy #celltherapy #biotechinnovation

The Art of the Thank You is Not Dead — But It Needs a Revival. A few weeks ago, I had the honor of speaking to my old Lambda Chi Alpha chapter at the University of Kansas about resumes, job search strategies, and interview prep. We shared stories, laughs, and some hard truths and I walked away inspired. But what really hit me? A few days later, they sent me a handwritten card. Every single one of those young men signed it. No ask. No agenda. Just thanks. "Brother Austin, we appreciate your dedicated time..." "Thank you for coming to speak and mentor us." That kind of gesture? It stays with you. ✅ It costs nothing. ✅ It builds relationships. ✅ It makes people feel seen. In a world speeding toward digital efficiency, personal appreciation is still a superpower. So here’s my challenge to you today: Who can you thank right now? A mentor. A colleague. A teacher. A client. Send a quick note. Make a call. Write the card. You’ll make someone’s day—and reinforce the kind of leadership this world desperately needs. #Networking #Leadership #Gratitude #ProfessionalGrowth #Mentorship #ThankYou

What’s slowing down regulatory submissions for NAb assays? It’s not the science—it’s the reporting. I recently sat in on a talk from Dr. Jason DelCarpini, Director of Bioanalytical and Molecular Assays at Moderna, and it was quite the lesson in clarity, leadership, and real-world problem-solving. Jason broke down a key issue in our field: inconsistent neutralizing antibody (NAb) reporting across ligand-binding and cell-based assays is creating confusion, review delays, and missed opportunities to streamline regulatory approval. So what’s the fix? The BAR Template—developed through an industry-led white paper Jason co-authored—is a proposed standard for NAb sample testing and reporting. It offers: ✔ Clear section-by-section guidance ✔ Transparent reporting of methods, controls, deviations, and analysis ✔ A common language regulators can quickly follow Instead of every lab reinventing the wheel, this framework promotes harmonization across submissions—something we desperately need with increasingly complex biologics and multi-domain therapies. This isn’t just about formatting—it’s about data integrity, transparency, and making sure regulators have the clarity they need to move safe and effective therapies forward faster. Big thanks to Jason and his co-authors for pushing the conversation forward. #bioanalysis #immunogenicity #regulatoryscience #clinicaltrials #biotech

If you’re building a biotech company (or thinking about it)... read this. Every guest brings something special, and this episode with KATRINA ROGERS is no exception — very engaging, full of bold insights and straight talk for biotech founders, executives, and scientists. Katrina Rogers has: ✓ Led ADME studies at Pfizer ✓ Advised startups and VCs across the biotech ecosystem ✓ Built innovation clusters from scratch ✓ Mentored countless underrepresented founders ✓ And reminds all of us that “The world needs your big idea.” We went deep on: ✓ Why the biggest mistake founders make is skipping customer discovery ✓ How to build your board before they do ✓ What the FDA really wants from you (“Show them your science”) ✓ And how culture and self-doubt are often our biggest barriers to impact Katrina also challenged us to reimagine how we train the next generation of biotech innovators — not just PhDs, but the skilled technical workforce that makes the entire system run. There’s wisdom, vulnerability, and hard truths in this one. If you’re a founder, scientist, investor, or just someone with a big idea—you’ll want to hear this. 👉 Link in comments #Biotech #Leadership #BioTalkUnzipped #LifeSciences #Founders

What a time we had for dinner and scientific discussion at Ocean Prime on Monday at AAPS NBC!! Johannes Stanta led an interactive discussion on how bioanalytical methods must adapt as cell-based, organ-on-chip, and tissue models begin to replace traditional GLP safety testing, following new FDA guidance. A timely topic with a rich discussion across the group. It mixed well with some great scientific networking and delicious food! We visited old friends and made some new ones and came out a bit wiser on what's next in GLP safety testing. Thanks to John Haug, Angela Medd for your help in planning this event and for my wonderful colleagues, Emanuel Owens, Allan Cortes, Chad Briscoe, Leslie Poli, Jo Goodman, and Soumya Mohana Sundaram for making everyone feel welcome! Austin Crow and the Ocean Prime team did a fabulous job making this a great evening we hope to repeat in the future. If you weren't able to make it - reach out to me about the next one. I look forward to seeing you all again soon! #scientific #dinner #GLP #testing #FDA #AAPS #NBC

Going to AAPS NBC (National Biotechnology Conference) in Boston next week? Please stop by our booth and say "hello". I'd love to see you and catch up! Safe travels. #AAPS #AAPSNBC #biotech #conference